In an interview with Tip TV, Declan Service, CEO of Integumen, talks about the product line, not being a pharmaceutical company and the company’s future plans.
Its products focus on the areas skin care, oral care and wound care. Integumen plans to commence dealing on the AIM (Alternative Investment Market) in London on April 5.
Service says the company’s primary focus after raising money via IPO is “to ramp up sales in the existing products and also work with the new technologies. When quipped about Brexit uncertainty, Service replies “At the moment it is helping us in terms of exports (due to weak Pound). “
Watch the full segment for more info on Integumen’s target markets.